Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In preclinical work the fragment has also been linked to angiogenesis (new blood-vessel growth, including VEGF signalling), recruitment of stem and progenitor cells, and reduced inflammation and fibrosis [5] [6]
What You Get: Initial 60-min physician intake ($200) Monthly 15-min check-ins (weigh-in + body comp) 4 weekly sub-Q GLP-1 injections (Semaglutide, Tirzepatide, or Retatrutide, depending on your personalized treatment plan)
Certain combinations may not be appropriate depending on medical history and treatment goals
Your inhibitions are lowered, and your reasoning and memory are impaired slightly
You know what I mean
The honest answer is that the human safety data is limited compared to decades-old pharmaceuticals, but the preclinical safety record across multiple species is unusually clean for a peptide with this level of biological activity
